Literature DB >> 26842624

IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

R Brugnano1, R Del Sordo2, C Covarelli2, E Gnappi3, S Pasquali3.   

Abstract

Immunoglobulin (Ig)M nephropathy (IgMN), known since 1978, is a very controversial clinicopathological entity characterized by IgM diffuse deposits in the mesangium at immunofluorescence whereas light microscop identifies minimal glomerular lesion, hypercellularity and expansion of the mesangium or sclerotic focal, segmental lesion. Clinically, it is a nephrotic syndrome, especially in pediatric patients, or asymptomatic proteinuria and/or isolated hematuria. These characteristics narrowly define IgMN between minimal change disease and focal segmental glomerulosclerosis, so it is not often recognized as a separate pathology. Homogeneous epidemiologic, pathogenetic, clinical or histological data are not available. Recent research on the pathogenetic role of mesangial IgM has, however, renewed interest in IgMN and naturally the controversies.

Entities:  

Keywords:  Controversy; Focal segmental glomerulosclerosis; IgM nephropathy; Minimal change disease; Nephrotic syndrome

Mesh:

Substances:

Year:  2016        PMID: 26842624     DOI: 10.1007/s40620-016-0269-6

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  41 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

2.  IgM-associated primary diffuse mesangial proliferative glomerulonephritis: natural history and prognostic indicators.

Authors:  D J O'Donoghue; W Lawler; L P Hunt; E J Acheson; N P Mallick
Journal:  Q J Med       Date:  1991-04

3.  An analysis of 3,555 cases of renal biopsy in Thailand.

Authors:  Paisal Parichatikanond; Ratana Chawanasuntorapoj; Chairat Shayakul; Boonyarit Choensuchon; Somkiat Vasuvattakul; Kriengsak Vareesangthip; Thawee Chanchairujira; Suchai Sritippayawan; Attapong Vongwiwatana; Nalinee Premasathian; Kraiwiporn Kiattisunthorn; Ratana Larpkitkachorn; Leena Ongajyooth
Journal:  J Med Assoc Thai       Date:  2006-08

4.  Immunohistologic features of minimal-change nephrotic syndrome.

Authors:  D R Prasad; S W Zimmerman; P M Burkholder
Journal:  Arch Pathol Lab Med       Date:  1977-07       Impact factor: 5.534

Review 5.  Mesangial IgM nephropathy.

Authors:  A Tejani; A D Nicastri
Journal:  Nephron       Date:  1983       Impact factor: 2.847

6.  Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.

Authors:  T Cavallo; M P Johnson
Journal:  Nephron       Date:  1981       Impact factor: 2.847

7.  Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.

Authors:  S Westphal; S Hansson; L Mjörnstedt; J Mölne; S Swerkersson; S Friman
Journal:  Transplant Proc       Date:  2006-10       Impact factor: 1.066

8.  Mesangial proliferative glomerulonephritis.

Authors:  H K Bhasin; J G Abuelo; R Nayak; A R Esparza
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

Review 9.  Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.

Authors:  José G van den Berg; Jan J Weening
Journal:  Clin Sci (Lond)       Date:  2004-08       Impact factor: 6.124

10.  Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

Authors:  Joshua M Thurman; Maria Wong; Brandon Renner; Ashley Frazer-Abel; Patricia C Giclas; Melanie S Joy; Diana Jalal; Milena K Radeva; Jennifer Gassman; Debbie S Gipson; Frederick Kaskel; Aaron Friedman; Howard Trachtman
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more
  5 in total

1.  A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis and nephrotic syndrome in an adult.

Authors:  Kyoung Sook Park; Ea Wha Kang; Jeong Hae Kie
Journal:  BMC Nephrol       Date:  2019-08-27       Impact factor: 2.388

2.  Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.

Authors:  Taisuke Irifuku; Ayaka Satoh; Hiroki Tani; Kouichi Mandai; Takao Masaki
Journal:  CEN Case Rep       Date:  2019-10-11

3.  IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease.

Authors:  Cheng-Wen Yang; Fan-Yu Chen; Fu-Pang Chang; Yang Ho; Bo-Sheng Wu; An-Hang Yang; Der-Cherng Tarng; Chih-Yu Yang
Journal:  BMC Nephrol       Date:  2021-01-12       Impact factor: 2.388

4.  Late relapse of IgM nephropathy-associated nephrotic syndrome after repeated administration of immune checkpoint inhibitor against pulmonary adenocarcinoma.

Authors:  Kentaro Odani; Mitsuhiro Tachibana; Fumiaki Nogaki; Yutaka Tsutsumi
Journal:  Clin Case Rep       Date:  2021-03-02

5.  Clinical significance of IgM deposition in pediatric minimal change disease.

Authors:  Duaa M Al Romaili; Turki O Al-Hussain; Hazem S Awad; Sermin A Saadeh; Ibrahim A Al-Hassoun; Turki A Al-Shareef
Journal:  Int J Pediatr Adolesc Med       Date:  2019-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.